NCT00019318View on ClinicalTrials.gov

Depsipeptide in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1997

Conditions
Lymphoma
Interventions
DRUG

romidepsin

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019318 - Depsipeptide in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter